# OnCo record ubix-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ubix-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ubix-therapeutics" ;
  schema:name "Ubix Therapeutics"@en ;
  schema:alternateName "Ubix Therapeutics, Inc."@en, "유빅스테라퓨틱스"@en ;
  schema:description "Ubix Therapeutics is a Korean company making medicines that make cancer cells break down a target protein rather than just block it. Its lead drug destroys BTK, a protein that drives B-cell blood cancers, including forms resistant to current BTK inhibitors."@en ;
  schema:url <https://onco.cc/companies/ubix-therapeutics/>, <https://ubixtrx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://ubixtrx.com/>, <https://ubixtrx.com/pipeline>, <https://clinicaltrials.gov/study/NCT06590961> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/btk/> .